References relevant to drug promotion: 2004
This page lists all the 793 references relevant to drug promotion in the Healthy Skepticism library that were published in 2004 .
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL892
Associated Press.
Eli Lilly Said to Know of Prozac Risks
Associated Press 2004 Dec 31
HSL894
Reuters .
FDA Warns Barr Over Seasonale Commercial
Reuters 2004 Dec 31
HSL6017
Mansfield PR, Jureidini JN, Parry P.
The belief that fluoxetine is effective for depressed children persists but is unjustified
BMJ 2004 Dec 31;330
http://bmj.bmjjournals.com/cgi/eletters/330/7481/7
HSL885
Meier B .
Medicine's Data Gap: Doctors, Too, Ask: Is This Drug Right?
The New York Times 2004 Dec 30
HSL893
Goldstein , R .
Intimidation, Politics and Drug Industry Cripple U.S. Medicine
Inter Press Service 2004 Dec 30
HSL897
Reuters.
Celebrex Prescriptions Plunge After Risks Identified
The Wall Street Journal 2004 Dec 30
HSL884
The ASSOCIATED.
Family of woman killed by AIDS test drug sues doctors
USA TODAY 2004 Dec 29
HSL946
Maher S.
US drug makers pressure Canberra
The Australian 2004 Dec 29
HSL879
Editorial .
Prescription for Confusion
THE NEW YORK TIMES 2004 Dec 28
HSL880
O'Connor , A .
Vioxx. Celebrex. Now Aleve. What's a Patient to Think?
The New York Times 2004 Dec 28
HSL870
Editorial /, S .
Take drugs off the market
USA Today 2004 Dec 27
HSL871
Rost P.
Big Pharma's Dirty Little Secret
The LA Times 2004 Dec 26
HSL872
Krasner , J .
Stents sold despite high failure rates: BSX held off recall amid alarming data
The Boston Globe 2004 Dec 26
HSL874
Editoral .
FDA warnings
The Boston Globe 2004 Dec 26
HSL875
Hensley , S .
New risks put old drugs in spotlight
The Wall Street Journal 2004 Dec 26
HSL881
Goldstein , S .
Bill would shield some drug firms from punitive damages: A provision in medical malpractice legislation would protect manufacturers that meet FDA standards.
Philadelphia Inquirer 2004 Dec 26
HSL943
Hudson P.
What's in it for me?
The Hearld Sun 2004 Dec 26
HSL867
O'Gilfoil Healy, P .
Spitzer, in a Shift, Will Yield Inquiries to U.S. Regulators
The New York Times 2004 Dec 25
HSL868
Henderson D.
Calls are mounting for revamp of FDA
The Boston Globe 2004 Dec 25
HSL869
Siegel M.
Put the Brakes on the Wonder Drug Express
The Washington Post 2004 Dec 25
HSL1921
Raphael MF, Bouts AH, Sukhai RN.
[Sweets from the pharmaceutical industry reason to suspect intoxication with quetiapine] .
Ned Tijdschr Geneeskd 2004 Dec 25;148(52):2583-4
HSL873
Kerber , R .
22% of medical device follow-up studies left undone
The Boston Globe 2004 Dec 24
HSL272
Silverman E.
Choosing their words carefully
NJ Star-Ledger 2004 Dec 23
HSL863
Editorial .
The Sick NIH
The LA Times 2004 Dec 23
HSL876
Medicare to Test Ways to End Disparities Amid Evidence That Closing Treatment Gaps Saves More Lives Than R&D
Washington Health Policy Week in Review 2004 Dec 23
HSL883
Reuters .
Aleve Warnings May Be Exaggerated
The Wall Street Journal 2004 Dec 23
HSL271
Willman D.
The National Institutes of Health: Public Servant or Private Marketer?
The Los Angeles Times 2004 Dec 22
HSL864
Willman , D .
$508,050 From Pfizer, but No 'Outside Positions to Note'
The LA Times 2004 Dec 22
HSL865
William D.
Case study| Dr. Lance A. Liotta and Emanuel F. 'Chip' Petricoin III: Firm's Research Stalls as Cancer Experts Work for Rival
The LA Times 2004 Dec 22
HSL866
William D.
Case Study| Dr. Harvey G. Klein: Public Pays for Blood Expert's Advice, and So Do Firms
The LA Times 2004 Dec 22
HSL882
Heavey , S .
FDA Says AstraZeneca Crestor Ad Is Misleading
Reuters 2004 Dec 22
HSL955
Willman D.
The National Institutes of Health: Public Servant or Private Marketer?
THE LOS ANGELES TIMES 2004 Dec 22
HSL252
Maher S.
Heart monitor on arthritis drug
The Australian 2004 Dec 21
HSL265
Harris G.
A 4th Painkiller Is Tied to Increased Heart Risk
The New York Times 2004 Dec 21
HSL269
Goozner M.
Op-Ed Contributor: Overdosed and Oversold
New York Times 2004 Dec 21
HSL270
Rowland C.
The Boston Globe
Drug makers revamping clinical-trial system: New test strategies focus on weeding out duds sooner 2004 Dec 21
HSL250
Getting a Toehold for Research Comparing Medical Treatments
Washington Health Policy Week in Review 2004 Dec 20
HSL254
Saunders M.
Arthritis drug wins backing
The Australian 2004 Dec 20
HSL256
Pfizer to stop advertising painkiller: report
ABC News Online 2004 Dec 20
HSL877
Grassley Plays Up Role as Government Watchdog, Focuses on FDA
Washington Health Policy Week in Review 2004 Dec 20
HSL942
Harvey M, Frenkel J.
PBS fix-it plan to save billions
The Hearld Sun 2004 Dec 20
HSL889
Meier B .
Medicine Fueled by Marketing Intensified Trouble for Pain Pills
The New York Times 2004 Dec 19
HSL2
Mansfield P.
Accepting what we can learn from advertising's mirror of desire.
BMJ 2004 Dec 18;329(7480):1487-8
Link to source with long URL
HSL244
New Doubts About Celebrex
THE NEW YORK TIMES 2004 Dec 18
HSL268
Pugh T, Borenstein S.
American Consumers Suffering as More New Drugs Debut in US, Analysis Shows
Knight-Ridder 2004 Dec 18
HSL908
Berenson , A .
Pricey Drug Trials Turn Up Few New Blockbusters
The New York Times 2004 Dec 18
HSL1922
Offerhaus L.
[The pharmaceutical industry in scandal: Mercury or Aesculapius?]
Ned Tijdschr Geneeskd 2004 Dec 18;148(51):2554-6
HSL2389
Scott T, Stanford N, Thompson DR.
Killing me softly: myth in pharmaceutical advertising.
BMJ 2004 Dec 18;329(7480):1484-7
Link to source with long URL
HSL233
Pfizer's statement on Celebrex: Firm finds one of two studies showed patients on Celebrex had an increased risk of heart attacks.
CNN 2004 Dec 17
HSL235
Hensley .
Pfizer Says Study Shows Heart Risk From Celebrex: Shares Sink 11% on News
Wall Street Journal 2004 Dec 17
HSL248
Pfizer Statement on New Information Regarding Cardiovascular Safety of Celebrex: Dosing in Long-Term Cancer Studies Suspended Due to Increased Cardiovascular Risk in One Study; Preliminary Analysis of Second Long-Term Cancer Study Shows No Increased Cardi
Pfizer.com 2004 Dec 17
HSL1421
Mandatory Reporting of Adverse Drug Reactions: An important first step
Canadian Women's Health Network 2004 Dec 17
HSL2321
Young T.
Medication Errors Involving Reminyl* and Amaryl
Janssen-Ortho Inc. & Aventis Pharma Inc.. 2004 Dec 17
HSL167
Sarasohn J.
Tauzin to Head Drug Trade Group
The Washington Post 2004 Dec 16
HSL172
Kaufman M.
Many FDA Scientists Had Drug Concerns, 2002 Survey Shows
The Washington Post 2004 Dec 16
HSL178
Bias seen in U.S. drug study reporting
United Press International 2004 Dec 16
HSL246
Prescription Drugs: About One-Fifth of FDA Scientists Felt Pressured To Approve Medications, Despite Safety Concerns, Survey Shows
Kaiser Daily Health Policy Report 2004 Dec 16
HSL890
Lueck , S .
Tauzin Is Named Top Lobbyist For Pharmaceuticals Industry: Departing Congressman Is Former Head of Panel That Oversaw Drug Sector
THE WALL STREET JOURNAL 2004 Dec 16
HSL940
Generics See Evergreening as Red
Corrs In Brief 2004 Dec 16
HSL160
Meier B.
Flawed Device Places F.D.A. Under Scrutiny
The New York Times 2004 Dec 15
HSL166
Safety issue concerns Grassley: The senator sees his probe of the drug approval process as vital to consumers' well-being.
REGISTER WASHINGTON BUREAU 2004 Dec 15
HSL170
Weiss S.
Tauzin Raised Six-Figure Sum from Drug Makers: The New Head of PhRMA Enjoyed the Financial Support of Pharmaceutical Manufacturers While in Congress
Capital Eye 2004 Dec 15
HSL175
Solomon J, Herschaft R.
Woman Died During AIDS Study
The Associated Press 2004 Dec 15
HSL154
Zuger A.
We Love Them. We Hate Them. We Take Them.
The New York Times 2004 Dec 14
HSL149
Herper M.
Face Of The Year: David Graham
2004 Dec 13
HSL151
U.S. Officials Knew of AIDS Drug Risks: Top U.S. Officials Warned of Concerns Before AIDS Drug Sent to Africa
The Associated Press 2004 Dec 13
HSL179
Norton A.
Ads for body-imaging health screens may mislead
Reuters 2004 Dec 13
HSL147
Starr D.
The Cuban Biotech Revolution Embargo or no, Castro's socialist paradise has quietly become a pharmaceutical powerhouse. (They're still working on the capitalism thing.)
Wired Magazine 2004 Dec 12
HSL158
Johnston L.
My wife killed herself because of Prozac, so why is it still being prescribed?
SUNDAY EXPRESS 2004 Dec 12
HSL941
NUPGE hails victory in battle to end drug patent abuse
NUPGE 2004 Dec 12
HSL144
Rowland C.
High-profile ruling near for Maine, drug firms
The Boston Globe 2004 Dec 11
HSL138
Rabin R.
Pill study was wrong: Report touting health benefits from drug's use was flawed, didn't get OK from Women's Health Initiative
Newsday 2004 Dec 10
HSL141
Prozac is risky for children too
BBC News 2004 Dec 10
HSL136
Shipman report demands GMC reform
BBC News 2004 Dec 9
HSL137
Mangan K.
Medical Association Calls for End to Confidentiality Demands by Research Sponsors
The Chronicle of Higher Education 2004 Dec 9
HSL139
FDA Warns Heart-Bypass Patients Shouldn't Take Painkiller Bextra
The Wall Street Journal 2004 Dec 9
HSL140
Drug Maker Withheld Paxil Study Data: ABC News Uncovers Documents Unknown to Regulators and Many Doctors
ABC News 2004 Dec 9
HSL142
Carroll J.
Extreme Disease Deficit
San Francisco Chronicle 2004 Dec 8
HSL947
Metherell M.
New deadline for medicine costs pledge
Sydney Morning Heral 2004 Dec 8
HSL108
Boseley S.
Antidepressant pills 'too readily prescribed': Medicines regulator decides there is no evidence drugs cause increased self harm but inquiry criticised for not seeing full trial data
2004 Dec 7
HSL109
Vedantam S.
British Officials Advise Less Use of Antidepressants
The Washington Post 2004 Dec 7
HSL12236
Angell M.
Excess in the pharmaceutical industry.
CMAJ 2004 Dec 7;171(12):1451-3
http://www.cmaj.ca/cgi/content/full/171/12/1451
HSL106
Harris G.
At F.D.A., Strong Drug Ties and Less Monitoring
The New York Times 2004 Dec 6
HSL107
Boseley S.
Antidepressants to be ruled safe: Watchdog criticised for today's announcement
The Guardian 2004 Dec 6
HSL110
Hale V.
Creating More Paths to Hope
Newsweek 2004 Dec 6
HSL134
McCoy K.
Drugmaker rebuffed call to monitor users
USA TODAY 2004 Dec 6
HSL135
Britain overdoses on anti-depressants
The Daily Mail 2004 Dec 6
HSL488
Jureidini J, Tonkin A, Mansfield PR.
TADS study raises concerns.
BMJ 2004 Dec 4;329(7478):1343-4
http://bmj.bmjjournals.com/cgi/content/full/329/7478/1343-d
HSL163
Hirschler B.
Britain May Tighten Rules on Antidepressant Drugs
Reuters 2004 Dec 3
HSL1923
Finucane TE, Boult CE.
Association of funding and findings of pharmaceutical research at a meeting of a medical professional society.
Am J Med 2004 Dec 1;117(11):842-5
http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(04)00583-2
HSL2214
Fitzgerald MA.
Appropriate antibiotic prescribing. Guidance for the use of drug samples
Adv Nurse Pract. 2004 Dec 01;12(12):18-22
HSL5844
Muijrers PE, Janknegt R, Sijbrandij J, Grol RP, Knottnerus JA.
Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners.
Eur J Clin Pharmacol 2004 Dec 01;60(10):739-46
Link to source with long URL
HSL5874
Fontanarosa PB, Rennie D, DeAngelis CD.
Postmarketing surveillance--lack of vigilance, lack of trust.
JAMA 2004 Dec 1;292(21):2647-50
http://jama.ama-assn.org/cgi/content/full/292/21/2647
HSL5888
Lichtenberg P, Heresco-Levy U, Nitzan U.
The ethics of the placebo in clinical practice.
J Med Ethics 2004 Dec 01;30(6):551-4
Link to source with long URL
HSL486
Light DW, Lexchin J.
Will lower drug prices jeopardize drug research? A policy fact sheet
Am J Bioeth 2004 Winter;4(1):1-4
Nil
HSL1897
Douglas KM, Sutton RM.
Right about others, wrong about ourselves? Actual and perceived self-other differences in resistance to persuasion
Br J Soc Psychol 2004 Dec;43(Pt 4):585-603
Link to source with long URL
HSL1925
Waack KE, Ernst ME, Graber MA.
Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction.
Ann Pharmacother 2004 Dec;38(12):2029-34
http://www.theannals.com/cgi/content/full/38/12/2029
HSL1926
Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG.
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression.
Med Care 2004 Dec;42(12):1176-85
Link to source with long URL
HSL5392
Caplan A, Elliott C.
Is it ethical to use enhancement technologies to make us better than well?
PLoS Med 2004 Dec;1(3):e52
Link to source with long URL
HSL5394
Turner EH.
A taxpayer-funded clinical trials registry and results database.
PLoS Med 2004 Dec;1(3):e60
Link to source with long URL
HSL886
Meier B .
The Academic Connection: Contracts Keep Drug Research Out of Reach
The New York Times 2004 Nov 29
HSL1927
Food and Drug Administration, HHS.
Drug labeling; sodium labeling for over-the-counter drugs.
Federal Register 2004 Nov 29;69(228)
Link to source with long URL
HSL8077
Carey J, Barrett A, Cropper CM.
Lessons From The Vioxx Fiasco : What drugmakers, the FDA, doctors, and patients need to do
Business Week 2004 Nov 29
Link to source with long URL
HSL8615
Zarembo A.
Bayer Held Back on Drug Dangers
Los Angeles Times 2004 Nov 23:A12
Link to source with long URL
HSL891
Santini , L .
Drug Companies Look to China For Cheap R&D
THE WALL STREET JOURNAL 2004 Nov 22
HSL1373
L-carnitine
Med Lett Drugs Ther 2004 Nov 22;46(1196):95-6
HSL939
How the drug cartel thrives
Sunday Herald 2004 Nov 21
HSL240
Drug companies blinded by quest for profit
Montreal Gazette 2004 Nov 19
HSL241
Liberal's plan to get discount medicines to poor nations panned
Globe and Mail 2004 Nov 19
HSL5922
United States Senate Committee on Finance Web page
Testimony of David J. Graham, MD, MPH
: United States Senate Committee on Finance Web page; 2004 Nov 18
http://finance.senate.gov/hearings/testimony/2004test/111804dgtest.pdf
HSL4929
Mansfield PR.
Safety Query.
Australian Doctor Weekly 2004 Nov 17
HSL238
Proposal will save health cash: MP
Windsor Star 2004 Nov 15
HSL5823
Langton PE, Hankey GJ, Eikelboom JW.
Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions: we need processes in place to follow up suspicions about serious adverse events.
Med J Aust 2004 Nov 15;181(10):524-5
http://www.mja.com.au/public/issues/181_10_151104/lan10728_fm.html
HSL12232
Anand G.
How Drugs for Rare Diseases Became Lifeline for Companies
The Wall Street Journal 2004 Nov 15:A1
Link to source with long URL
HSL2095
Abraham J.
Pharmaceuticals, the state and the global harmonisation process.
Aust Health Rev 2004 Nov 8;28(2):150-60
Link to source with long URL
HSL933
Moran , M .
AMA to Study Safety of SSRIs In Youngsters
Psychiatric News 2004 Nov 5
HSL2143
Bellin M, McCarthy S, Drevlow L, Pierach C.
Medical students' exposure to pharmaceutical industry marketing: a survey at one U.S. medical school.
Acad Med. 2004 Nov;79(11):1041-5. 2004 Nov 01;79(11):1041-5
http://www.academicmedicine.org/cgi/content/full/79/11/1041
HSL5960
Dybdahl T, Andersen M, Sondergaard J, Kragstrup J, Kristiansen IS.
Does the early adopter of drugs exist ? A population-based study of general practitioners' prescribing of new drugs.
Eur J Clin Pharmacol 2004 Nov 01;60(9):667-72
Link to source with long URL
HSL487
Mansfield PR, Henry D.
Misleading drug promotion--no sign of improvements.
Pharmacoepidemiol Drug Saf 2004 Nov;13(11):797-9
http://www3.interscience.wiley.com/cgi-bin/abstract/107632790/ABSTRACT
HSL416
Allen K, Mansfield P.
Changing attitudes to 'the change'.
Aust Fam Physician 2004 Nov;33(11):939-40
http://www.racgp.org.au/document.asp?id=15004
HSL1347
Wazana A, Granich A, Primeau F, Bhanji NH, Jalbert M.
Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry.
Acad Med 2004 Nov;79(11):1033-40
http://www.academicmedicine.org/cgi/content/full/79/11/1033
HSL1722
Lankinen KS, Levola T, Marttinen K, Puumalainen I, Helin-Salmivaara A.
Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals.
Pharmacoepidemiol Drug Saf 2004 Nov;13(11):789-95
http://www3.interscience.wiley.com/cgi-bin/abstract/109712611/ABSTRACT
HSL2081
Brownfield ED, Bernhardt JM, Phan JL, Williams MV, Parker RM.
Direct-to-consumer drug advertisements on network television: an exploration of quantity, frequency, and placement.
J Health Commun 2004 Nov-Dec;9(6):491-7
Link to source with long URL
HSL2092
Ahmed SB, Grace SL, Stelfox HT, Tomlinson G, Cheung AM.
Gender bias in cardiovascular advertisements.
J Eval Clin Pract 2004 Nov;10(4):531-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2003.00483.x
HSL2093
Ahmed SB, Grace SL, Stelfox HT, Tomlinson G, Cheung AM.
Portrayal of female physicians in cardiovascular advertisements.
Can J Cardiol 2004 Nov;20(13):1351-4
HSL2094
Agrawal S, Saluja I, Kaczorowski J.
A prospective before-and-after trial of an educational intervention about pharmaceutical marketing.
Acad Med 2004 Nov;79(11):1046-50
http://www.academicmedicine.org/cgi/content/full/79/11/1046
HSL2208
O'Donnell MJ, Molloy DW, Smith SD, Dubois S, Russo RM.
The self-perceived role and educational needs of pharmaceutical representatives: a survey.
Educ Health (Abingdon) 2004 Nov;17(3):339-45
HSL2210
Huh J, Cude BJ.
Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
J Health Commun 2004 Nov-Dec;9(6):529-40
Link to source with long URL
HSL5393
Moynihan R.
The intangible magic of celebrity marketing.
PLoS Med 2004 Nov;1(2):e42
Link to source with long URL
HSL500
Sweet M.
Doctors and drug companies are locked in 'vicious circle'.
BMJ 2004 Oct 30;329(7473):998
http://bmj.bmjjournals.com/cgi/content/full/329/7473/998
HSL6018
Mansfield PR.
Reform of incentives would help reduce harm from drug promotion
BMJ 2004 Oct 30;329
http://bmj.bmjjournals.com/cgi/eletters/329/7473/998
HSL12894
Gabbay J, le May A.
Evidence based guidelines or collectively constructed "mindlines?" Ethnographic study of knowledge management in primary care
BMJ 2004 Oct 30;329(7473):1013
http://www.bmj.com/cgi/content/full/329/7473/1013
HSL1177
Ranald P.
A clear choice: abandon or defend FTA
Australian Financial Review 2004 Oct 22
HSL1175
Davidson K.
Can we please get serious?: The US free trade deal may be a disaster for Australia. Not that our politicians seem to care
The Age 2004 Oct 21
HSL2215
Aasland OG, Forde R.
[Physicians and drug industry: attitudes and practice].
Tidsskr Nor Laegeforen 2004 10 21;124(20):2603-6
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1083681
HSL4138
Topol EJ.
Failing the public health--rofecoxib, Merck, and the FDA.
N Engl J Med 2004 Oct 21;351(17):1707-9
http://content.nejm.org/cgi/content/extract/351/17/1707
HSL5966
Fitzgerald GA.
Coxibs and cardiovascular disease.
N Engl J Med 2004 Oct 21;351(17):1709-11
http://content.nejm.org/cgi/content/extract/351/17/1709
HSL1173
Hensley S, Hollister H.
Pfizer Reports Solid Earnings;Wyeth Returns to Profitability Restrained Drug-Price Rise May Slow Growth
Wall Street Journal 2004 Oct 20
HSL1174
Mitchell A.
PBS faces winds of change
Australian Financial Review 2004 Oct 20
HSL1171
Pollack A.
A New Trial of Celebrex, and Questions on Its Timing
The New York Times 2004 Oct 19
HSL1172
Hensley S.
FDA Says It Is Too Soon to Tell If Vioxx's Risks Apply to Class Merck's Recall Decision Raises Safety Questions In Similar Arthritis Drugs
Wall Street Journal 2004 Oct 19
HSL1138
Gladwell M.
High Prices: How to think about prescription drugs.
The New Yorker 2004 Oct 18
HSL1141
Masters B.
Painful Withdrawal for Makers of Vioxx: Pulling of Arthritis Drug Raises Questions on Marketing, Safety Risks
The Washington Post 2004 Oct 18
HSL1169
Consumers Sue Pharmaceutical AstraZeneca Over Misleading Nexium Campaign - AFL-CIO joins suit alleging scheme to deceive consumers, increase profits
Prescription Access Litigation 2004 Oct 18
HSL1170
Hensley S.
Pfizer to Test All-or-Nothing Bet Could Pave Way for Broader Use Of Popular Arthritis Drug
Wall Street Journal 2004 Oct 18
HSL1136
Abelson R.
Pfizer Warns of Risks From Its Painkiller
The New York Times 2004 Oct 16
HSL1134
Silverman E.
Drug maker promotes generics for workers Novartis draws fire on cost-cutting bid
The Star-Ledger 2004 Oct 15
HSL6019
Mansfield PR.
Reply to Stephen Black and Nicholas DeMartinis
2004 Oct 15;329
http://bmj.bmjjournals.com/cgi/eletters/329/7468/748
HSL1132
Herper M.
Merck's Missing Vioxx Study
Forbes 2004 Oct 14
HSL1125
Goar C.
Is drug watchdog on duty for us?
Toronto Star 2004 Oct 11
HSL499
Mansfield PR.
Banned drug's world of faceless victims
The Independent Weekly (Adelaide) 2004 Oct 10-16
HSL6020
Mansfield PR, Tonkin AL, Jureidini JN.
Antidepressants do less good than harm for children and adolescents
BMJ 2004 Oct 8;329
http://bmj.bmjjournals.com/cgi/eletters/329/7470/809
HSL1120
Herper M.
Fuzzy Drug Company Math
Forbes 2004 Oct 5
HSL1123
Haskell M.
New law cancels drug benefit Valium, Xanax among Rx cuts
Bangor Daily News 2004 Oct 5
HSL1099
Boseley S.
Drugs licensing flaws exposed: Pfizer advised on how to get antidepressant approved by member of body deciding on application
The Guardian 2004 Oct 4
HSL1101
Evans R.
The drugs industry and its watchdog: a relationship too close for comfort?
The Guardian 2004 Oct 4
HSL1106
Brownlee S.
Mysteries of the Mind
The Washington Post 2004 Oct 4
HSL1109
FDA should have required Vioxx safety study years ago, says Vanderbilt professor
SCRIP - World Pharmaceutical News 2004 Oct 4
HSL1110
Regulators deal with aftermath of Vioxx withdrawal
SCRIP - World Pharmaceutical News 2004 Oct 4
HSL1113
Pollack A.
New Scrutiny of Drugs in Vioxx's Family
New York Times 2004 Oct 4
HSL1114
Wilde Mathews A
Vioxx Recall Raises Questions On FDA's Safety Monitoring
The Wall Street Journal 2004 Oct 4
HSL1096
Freguson R.
MD deal aims to trim drugs for poor $50M fee hike if $200M in costs cut: Secret accord in tentative Ontario pact
The Toronto Star 2004 Oct 3
HSL1060
Topol E.
Good Riddance to a Bad Drug
New York Times 2004 Oct 2
HSL1061
Vioxx Withdrawal
ABC RN AM 2004 Oct 2
HSL4268
Benderly BL.
Advocacy groups are crucial players in developing new neurotherapeutics.
NeuroRx 2004 Oct 01;1(4):500-2
Link to source with long URL
HSL1059
Seaman B.
Treating infertility: Amid a confusing array of resources, how to decide which you can trust
Women's Review of Books 2004 Oct
HSL5255
Bensley RJ, Mercer N, Brusk JJ, Underhile R, Rivas J, Anderson J, Kelleher D, Lupella M, de Jager AC.
The eHealth Behavior Management Model: a stage-based approach to behavior change and management.
Prev Chronic Dis 2004 Oct;1(4):A14
Link to source with long URL
HSL5395
Pecoul B.
New drugs for neglected diseases: from pipeline to patients.
PLoS Med 2004 Oct;1(1):e6
HSL5437
Gupta AS.
Intellectual capital as property.
Indian J Med Ethics 2004 Oct-Dec;1(4):115-6
HSL13653
Carver N, Ashmore R, Rolfe G, Cutcliffe J.
Anything to declare? Competing interests in mental health nursing journals.
Journal of Psychiatric & Mental Health Nursing 2004 Oct-Nov;11(5):620-2
http://www.blackwellpublishing.com/journal.asp?ref=1351-0126&site=1
HSL14005
Poor Markets, Rich Rewards: Pharmaceuticals and poor countries
The Economist 2004 Sep 30:56
http://www.economist.com/business/displaystory.cfm?story_id=E1_PNVPDDQ
HSL5836
Abdolrasulnia M, Collins BC, Casebeer L, Wall T, Spettell C, Ray MN, Weissman NW, Allison JJ.
Using email reminders to engage physicians in an Internet-based CME intervention.
BMC Med Educ 2004 Sep 29;4(17)
Link to source with long URL
HSL1058
Faunce T.
It's time - for a bipartisan stand-firm
Sydney Morning Herald 2004 Sep 28
HSL1057
Schafer A.
Cracking down on medical trials
The Toronto Star 2004 Sep 27
HSL1051
Kanapaux W.
FDA likely to add black box warning for antidepressants
First World 2004 Sep 24
HSL1052
Shogren E.
Lawmakers Take FDA to Task on Antidepressants: A House subcommittee says the agency held back data on the drugs' risks to children
LA Times 2004 Sep 24
HSL1053
Harris G.
Warnings Called Likely on Drug Risk for Suicide
The New York Times 2004 Sep 24
HSL1054
Cohen R.
Regulators deny they covered up suicide info: FDA says antidepressant findings needed scrutiny
STAR-LEDGER 2004 Sep 24
HSL1055
Vedantam S.
FDA Told Its Analyst to Censor Data on Antidepressants
The Washington Post 2004 Sep 24
HSL182
Raghavan.a , Naik.g
A Tie-Up of Aventis, Sanofi Could Create Strong Global Rival
The Wall Street Journal 2004 Sep 23
HSL1050
Reuters .
US Reviewer Says Pressured in Antidepressant Probe
The New York Times 2004 Sep 23
HSL484
Cato J.
Pittman defense wants access to drug documents
The Herald 2004 Sep 22
HSL3486
Baker D
Financing Drug Research: What Are the Issues?
Washington DC: Center for Economic and Policy Research; 2004 Sep 21
Link to source with long URL
HSL1049
Drug Study Registries Raise Competitive Concerns (for Big Pharma)
Reuters 2004 Sep 20
HSL13403
Smoller JW.
The Etiology and Treatment of Childhood
New Media Explorer 2004 Sep 19
Link to source with long URL
HSL1048
Tenpenny S.
Vaccines: An Online Conference: The Flu Season Campaign Begins
Redflagsdaily.com 2004 Sep 17
HSL1047
Tell Truth About Antidepressants: On drug labels and in medical journals
Newsday.com 2004 Sep 16
HSL1046
For Honest Reports of Drug Trials
The New York Times 2004 Sep 11
HSL1056
Meet the people shaping the future of science: Cures before cash
Interview New Scientist 2004 Sep 4
HSL1045
Vranica S.
Drug Maker, Talent Agency Team Up to Place Product In Entertainment Venues
The Wall Street Journal 2004 Sep 2
HSL1043
Miller H.
The Truth About Marcia Angell
Tech Central Station 2004 Sep 1
HSL1044
Cassels A.
We can swing no-frills Pharmacare
Vancouver Sun 2004 Sep 1
HSL4931
Saunders C.
Program targets drug rep input.
Australian Doctor Weekly 2004 Sep 1
HSL5870
Elliott C.
Pharma goes to the laundry: Public relations and the business of medical education.
Hastings Cent Rep 2004 Sep-Oct 01;34(5):18-23
HSL2091
Andrews E, Dombeck M.
The role of scientific evidence of risks and benefits in determining risk management policies for medications.
Pharmacoepidemiol Drug Saf 2004 Sep;13(9):599-608
http://www3.interscience.wiley.com/cgi-bin/abstract/105560406/ABSTRACT
HSL2821
Donohue JM, Berndt ER.
Effects of Direct-to-Consumer Advertising on Medication Choice: The Case of Antidepressants
Journal of Public Policy & Marketing 2004 Fall;23(2):115–127
Link to source with long URL
HSL5092
Oldani MJ.
Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
Med Anthropol Q 2004 Sep;18(3):325-56
HSL14003
Druss BG, Marcus SC, Olfson M, Pincus HA.
Listening to generic Prozac: winners, losers, and sideliners.
Health Aff (Millwood) 2004 Sep-Oct;23(5):210-6
http://content.healthaffairs.org/cgi/content/full/23/5/210
HSL14036
Oldani MJ.
Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
Med Anthropol Q 2004 Sep;18(3):325-56
http://www.ncbi.nlm.nih.gov/pubmed/15484967
HSL14044
Vatjanapukka V, Waryszak R.
Relationship between consumer knowledge, prescription drug advertising exposure and attitudes towards direct-to-consumer prescription drug advertising
International Journal of Medical Marketing 2004 Sep;4(4):350-360
Link to source with long URL
HSL668
Martinez B.
Merck Dealt Setback by Zocor Study: In Cholesterol-Drug Battle, Large-Dose Regime Failed To Help High-Risk Patients
Wall Street Journal 2004 Aug 31
HSL665
Vergano D.
Scientists want research papers freely available
USA TODAY 2004 Aug 29
http://www.usatoday.com/news/science/2004-08-29-free-research_x.htm
HSL667
Day M.
Doctors' body accuses drug firms of 'disease mongering'
The Daily Telegraph 2004 Aug 29
HSL663
Mathews A.
Big HMO Reconsiders Vioxx After Study Points to Heart Risks
The Wall Street Journal 2004 Aug 26
HSL664
Quiggin J.
Labor must stand firm
Australian Financial Review 2004 Aug 26
HSL659
Pharmaceutical Drug Marketing Budgets Surpass $500 Million, Studies Show
PRNewswire 2004 Aug 25
HSL660
Allen L.
Gillard's $1bn plan for drugs
Australian Financial Review 2004 Aug 25
HSL661
Top U.S. Newspaper's Focous On Balance Skewed Coverage Of Global Warming, Analysis Reveals
2004 Aug 25
HSL658
Ipsos: Branded drug prices spurring non-compliance
Eyeforpharma 2004 Aug 24
HSL654
Roberts P.
Biota votes Australia best for research
Australian Financial Review 2004 Aug 23
HSL655
A marvel of modern medicine, and more
The Melbourne Age 2004 Aug 23
HSL656
Bremmer I.
To fight terrorism 'drug', US needs a demand-side strategy
The Australian 2004 Aug 23
HSL657
Bremmer .
To fight terrorism 'drug', US needs a demand-side strategy
The Australian 2004 Aug 23
HSL653
Gellene D.
'Mr. Botox' Case Raises Some Brows
LA Times 2004 Aug 22
HSL649
Mathews J, Thurbon E.
Bitter pill for an appendage state
2004 Aug 20
HSL650
Maine Inmate Sues OxyContin Maker
Join Together Online 2004 Aug 20
HSL652
Moss L.
Call to monitor drugs as antidepressants kill 500 people a year
Independent News 2004 Aug 20
HSL647
Angell M.
Drugmakers "Blackmail the Public"
Business Week 2004 Aug 18
HSL645
Harrison J.
OxyContin maker sued by state prison inmate
Bangor Daily News 2004 Aug 17
HSL1160
Moyers B.
Media That Set Us Free
YES! Magazine 2004 Aug 11
HSL1889
Mansfield PR.
A 5 minute read re drug promotion: RCT
Poster presented at 8th World Congress on Clinical Pharmacology & Therapeutics (CPT2004) Brisbane 2004 Aug 1-6
HSL5473
Phillips GC.
Medicolegal issues and ergogenic aids: trade, tragedy, and public safety, the example of ephedra and the Dietary Supplement Health and Education Act.
Curr Sports Med Rep 2004 Aug 01;3(4):224-8
HSL9688
Halperin EC, Hutchison P, Barrier RC Jr.
A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
Int J Radiat Oncol Biol Phys 2004 Aug 1;59(5):1477-83
http://linkinghub.elsevier.com/retrieve/pii/S0360301604002639
HSL2109
Reist D, Vandecreek L.
The pharmaceutical industry's use of gifts and educational events to influence prescription practices: Ethical dilemmas and implications for psychologists
Professional psychology-research and practice 2004 Aug;35(4):329-335
HSL9306
Leading Clinician Calls for New Approach to Atopic Eczema Treatment at International Gathering of Patients’ Groups
World Allergy Organization 2004 Aug
http://www.worldallergy.org/media/press_releases/atopic_eczema.html
HSL662
California Pharmacies Sue Drug Makers, Allege Price Fixing
The Wall Street Journal 2004 Jul 26
HSL651
Morais R.
Prozac Nation? Is the Party Over?
FORBES.com 2004 Jul 20
HSL225
Roehr B.
Stronger sanctions needed against companies that suppress data.
BMJ 2004 Jul 17;329(7458):132
http://bmj.bmjjournals.com/cgi/content/full/329/7458/132
HSL2076
Centers for Disease Control and Prevention (CDC).
Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
MMWR Morb Mortal Wkly Rep 2004 Jul 16;53(27):603-6
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5327a1.htm
HSL1977
MacKinnon NJ.
Use of drug samples as a threat to seamless health care.
Am J Health Syst Pharm 2004 Jul 15;61(14):1497-500
http://www.ajhp.org/cgi/reprint/61/14/1497.pdf
HSL226
Lenzer J.
Whistleblower charges medical oversight bureau with corruption.
BMJ 2004 Jul 10;329(7457):69
http://bmj.bmjjournals.com/cgi/content/full/329/7457/69
HSL227
Herxheimer A.
Open access to industry's clinically relevant data.
BMJ 2004 Jul 10;329(7457):64-5
http://bmj.bmjjournals.com/cgi/content/full/329/7457/64
HSL4955
Henson L.
Ego overload.
Australian Doctor Weekly 2004 Jul 5
HSL2818
Daikos GK.
Ethical dilemmas encountered during clinical drug trials.
Int J Antimicrob Agents 2004 Jul;24(1):24-31
Link to source with long URL
HSL2819
Romero CE, Baron JD, Knox AP, Hinchey JA, Ropper AH.
Barbiturate withdrawal following Internet purchase of Fioricet.
Arch Neurol 2004 Jul;61(7):1111-2
http://archneur.ama-assn.org/cgi/content/full/61/7/1111
HSL2820
Frankenberger KA, Frankenberger WR, Peden BF, Hunt HL, Raschick CM, Steller EG, Peterson JA.
Effects of information on college students' perceptions of antidepressant medication.
J Am Coll Health 2004 Jul-Aug;53(1):35-40
HSL5312
Pai SA.
Publication ethics policies for medical journals.
Indian J Med Ethics 2004 Jul-Sep;1(3):93
HSL5313
Kamtekar R.
Why life-saving drugs should be public goals.
Indian J Med Ethics 2004 Jul-Sep;1(3):77-8
HSL610
Reputations of Pharmaceutical and Health Insurance Companies Continue Their Downward Slide June 22, 2004
2004 Jun 30
HSL621
Letter to the Editor
Washington Post 2004 Jun 30
HSL622
Editorial: Missing Drug Data
The Washington Post 2004 Jun 30
HSL623
Evans R.
FoE joy as Bayer drops legal action
The Guardian 2004 Jun 30
HSL624
Pear R.
Investigators Say Drug Makers Repeatedly Overcharged
The New York Times 2004 Jun 30
HSL625
Hensley S.
Drug Firms Address Furor on Tests: New Guidance on Results Aims to Calm Concerns Over Negative Trial Data
The Wall Street Journal 2004 Jun 30
HSL626
Meier B.
Forest Asked to Supply Information on Marketing of Some Drugs
The New York Times 2004 Jun 30
HSL620
Wysocki B.
At Pitt, Scientists Decode The Secret of Getting Grants
The Wall Street Journal 2004 Jun 28
HSL607
Goozner M.
From The $800 Million Pill - Me Too!
Medscape 2004 Jun 27
HSL619
Fonda D.
Curbing The Drug Marketers - How a clampdown on pitching drugs for unapproved uses is changing the way Big Pharma operates
Time 2004 Jun 27
HSL338
Dodge , C .
Most U.S. Seniors Don't Know Medicare Bill Passed, Survey Shows
Bloomberg News 2004 Jun 26
HSL618
Meier B.
Drug Maker Acknowledges Some Negative Test Results
The New York Times 2004 Jun 26
HSL616
Martinez B.
Big U.S. firms could reap windfall
The Globe and Mail 2004 Jun 25
HSL617
Whiting R.
Drugmakers Respond To Calls For Public Database Of Trials
InformationWeek 2004 Jun 25
HSL614
Metherell M.
Experts haggling over drug listing secrecy
Sydney Morning Hearld 2004 Jun 24
HSL615
PBS: where the real threat is
Sydney Morning Hearld 2004 Jun 24
HSL611
Catherine MCGRATH.
Labor feels the heat over PBS backflip
The ABC 2004 Jun 23
HSL612
McGrath C.
Labor feels the heat over PBS backflip
The ABC 2004 Jun 23
HSL613
Meier B
Democrats Take a Look at Drug Tests
The New York Times 2004 Jun 23
HSL950
Bazell R.
Why are the new cancer drugs so expensive?
NBC News 2004 Jun 23
HSL606
Fox M.
Health Agency Proposes Ethics Crackdown
Reuters 2004 Jun 22
HSL608
Testimony to the Ways and Means Committee, U.S. House of Representatives US-Australia Free Trade Agreement: Implications for Prescription Drug Prices in the US and Australia
2004 Jun 22
HSL600
Frenkel J.
Clampdown on chemists to save $8b
The Herald Sun 2004 Jun 21
HSL601
Frenkel J.
Clampdown on chemists to save $8b
The Herald Sun 2004 Jun 21
HSL602
Tragic teen suicides inspire idea that invites more
USA Today 2004 Jun 21
HSL603
Meier B.
A Medical Journal Quandary: How to Report on Drug Trials
The New York Times 2004 Jun 21
HSL604
Tuller D
Gentlemen, Start Your Engines?
T he New York Times 2004 Jun 21
HSL596
Dr. Kate
It's time to focus on information bias about drugs
Times Star 2004 Jun 20
HSL597
Scannel K.
It's time to focus on information bias about drugs
Times Star 2004 Jun 20
HSL598
Gardiner H.
Antidepressants Restudied for Relation to Child Suicide
The New York Times 2004 Jun 20
HSL599
Hassner V.
Sharav Drugs' risks too great
USA Today 2004 Jun 20
HSL594
Inquiry into pharmaceutical industry a victory for consumer rights
Mind Chief Executive 2004 Jun 18
HSL595
New Inquiry - Terms of Reference: The Influence of the Pharmaceutical Industry
2004 Jun 18
HSL592
How to Find the Latest On Results of Clinical Trials As Groups Debate Access To Research, Existing Sources Of Information Are Growing
Wall Street Journal 2004 Jun 17
HSL593
Senator Says FDA Put Pressure On Staffer Over Antidepressants
The Wall Street Journal 2004 Jun 17
HSL8786
Zaneski CT.
Medical sales reps arrive bearing gifts
Baltimore Sun 2004 Jun 17
Link to source with long URL
HSL590
Whalen J.
Glaxo Releases Studies on Drug For Depression
The Wall Street Journal 2004 Jun 16
HSL591
AMA Supports Public Registry For Clinical Trials, Outcomes
The Wall Street Journal 2004 Jun 16
HSL4956
Efrat Z.
Under the influence
Australian Doctor Weekly 2004 Jun 16
HSL586
Gordon J, Wroe D.
PBS need not cost more: Labor
The Age 2004 Jun 15
HSL587
Fabro A.
FTA study claims drug costs will rise
Australian Financial Review 2004 Jun 15
HSL588
Meier B.
Group Weighs Plan for Full Drug-Trial Disclosure
The New York Times 2004 Jun 15
HSL589
AMA turns down proposal to ease guideline on gifts Doctor says policy ignored by many
Associated Press 2004 Jun 15
HSL2817
Grup d'Etica Societat Catalana de Medicina Familiar i Comunitaria.
[Ethics in drug industry relations.
Opinions poll of family physicians in Catalonia]Aten Primaria 2004 Jun 15;34(1):6-12
Link to source with long URL
HSL585
Condie .
Glaxo dismisses free trade concerns
Evening Standard 2004 Jun 14
HSL584
Cornacchia C.
Drugs: They don't Want to Go
There Monteal Gazette 2004 Jun 13
HSL581
Bad medicine
The Guardian 2004 Jun 12
HSL582
Yallop R.
Use it and lose it: end looms for antibiotics era
The Australian 2004 Jun 12
HSL577
Burling S.
Getting the bad news with the good news about a drug: The AMA may ask Health and Human Services to create a registry of all clinical trials and their results.
The Philadelphia Inquirer 2004 Jun 9
HSL579
Burling S.
Getting the bad news with the good news about a drug: The AMA may ask Health and Human Services to create a registry of all clinical trials and their results.
The Philadelphia Inquirer 2004 Jun 9
HSL580
Nearly a Quarter of Canadians Report a Preventable Adverse Event in Own Care or That of a Family Member: Fifth annual report showcases advances in patient safety and key health trends
The Canadian Institute for Health Information 2004 Jun 9
HSL576
Marre K.
PhRMA, Chamber team up to reduce worker depression
The Hill 2004 Jun 8
HSL573
Garnier comes out fighting
The Telegraph 2004 Jun 6
HSL575
Bischoff A.
Silence and Suicide
2004 Jun 6
HSL1496
Hallam K.
U.S. Senators Agree on Bill to Speed Generic Drugs to Market
Bloomberg News 2004 Jun 5
HSL569
Eyers J.
PBS politics 'a risk to R&D'
Financial Review 2004 Jun 4
HSL570
Weiss L, Thurbon E.
The FTA: pandering to Rome
Financial Review 2004 Jun 4
HSL1358
Toop L, Richards D.
Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows.
N Z Med J 2004 Jun 4;117(1195):U905
HSL1360
Toivianen H, Vuorenkoski L, Hemminki E.
Finnish physicians show little support for consumer advertising of prescription drugs.
N Z Med J 2004 Jun 4;117(1195):U907
HSL567
Bosley S.
We're losing the malaria battle
The Guardian 2004 Jun 3
HSL568
Meier B.
Two Studies, Two Results, and a Debate Over a Drug
The New York Times 2004 Jun 3
HSL627
Davidson K
Why rush a free trade deal, Mr Howard?
The Age 2004 Jun 1
HSL629
Davidson K.
Why rush a free trade deal, Mr Howard?
The Age 2004 Jun 1
HSL630
Press Release: Tangled Patent Linkages Reduce Stimulation for Pharmaceutical Innovation 6,730 patents for only 27 pharmaceutical inventions
European Generic Medicines Assocation 2004 Jun 1
HSL2085
Bojo Canales C, Carabantes Alarcon D, Veiga de Cabo J, Martinez Hernandez D.
[Bibliometric analysis of the Spanish Journal of Chemotherapy (1996-2000)]
Rev Esp Quimioterap 2004 Jun 01;17(2):161-8
http://www.seq.es/seq/0214-3429/17/2/161.pdf
HSL2809
Fabius AM, Cheung KC, Rijcken CJ, Vinkers CH, Talsma H.
Direct-to-consumer communication on prescription only medicines via the internet in the Netherlands, a pilot study. Opinion of the pharmaceutical industry, patient associations and support groups.
Pharm World Sci. 2004 Jun;26(3):169-72. 2004 Jun 01;26(3):169-72
Link to source with long URL
HSL2079
Caudill-Slosberg MA, Schwartz LM, Woloshin S.
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000.
Pain 2004 Jun;109(3):514-9
http://linkinghub.elsevier.com/retrieve/pii/S0304395904001307
HSL2810
Iijima H, Kamei M, Koshimizu T, Shiragami M.
Objective evaluation of generic drug information.
Yakugaku Zasshi 2004 Jun;124(6):341-7
http://www.jstage.jst.go.jp/article/yakushi/124/6/124_341/_article
HSL2811
Lofgren H, Boer R.
Pharmaceuticals in Australia: developments in regulation and governance.
Soc Sci Med 2004 Jun;58(12):2397-407
Link to source with long URL
HSL10328
Mark TL, Swait J.
Using stated preference and revealed preference modeling to evaluate prescribing decisions.
Health Econ 2004 Jun;13(6):563-73
HSL10337
Griffin MR, Stein CM, Ray WA.
Postmarketing surveillance for drug safety: surely we can do better.
Clin Pharmacol Ther 2004 Jun;75(6):491-4
Link to source with long URL
HSL10339
Cha R, Sobel JD.
Fluconazole for the treatment of candidiasis: 15 years experience.
Expert Rev Anti Infect Ther 2004 Jun;2(3):357-66
HSL10350
Rutter PM, Horsley E, Brown DT.
Evaluation of community pharmacists' recommendations to standardized patient scenarios.
Ann Pharmacother 2004 Jun;38(6):1080-5
http://www.theannals.com/cgi/content/full/38/6/1080
HSL2096
Snapinn S, Cook T, Shapiro D, Snavely D.
The role of the unblinded sponsor statistician.
Stat Med 2004 May 30;23(10):1531-3
http://www3.interscience.wiley.com/cgi-bin/abstract/108561305/ABSTRACT
HSL2808
Lachin JM.
Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
Stat Med 2004 May 30;23(10):1519-21
http://www3.interscience.wiley.com/cgi-bin/abstract/108561304/ABSTRACT
HSL497
Abboud L.
Lilly's New Pill For Depression Reopens Debate
The Wall Street Journal 2004 May 28
HSL2650
Garcia-Berthou E, Alcaraz C.
Incongruence between test statistics and P values in medical papers.
BMC Med Res Methodol 2004 May 28;4:13
http://www.biomedcentral.com/1471-2288/4/13
HSL494
Randerson J.
Antibiotics linked to huge rise in allergies
NewScientist.com 2004 May 27
HSL495
Italy police probe 4,400 doctors
BBC News 2004 May 27
HSL496
Windham C.
AMA to Propose Broad Database For Clinical Trials
Wall Street Journal 2004 May 27
HSL642
Garnaut J.
Plum jobs for US trade deal advisers
The Sydney Morning Herald 2004 May 27
HSL493
Buchanan K.
MP brands pill-making firms 'disease mongers'
The Western Mail 2004 May 26
HSL492
First, Do No Harm
The Wall Street Journal 2004 May 25
HSL641
Pear R.
In a Shift, Bush Moves to Block Medical Suits
The New York Times 2004 May 25
HSL640
Basu I.
India's clinical trials and tribulations
Asia Times Online 2004 May 23
HSL228
Lenzer J.
Pfizer pleads guilty, but drug sales continue to soar.
BMJ 2004 May 22;328(7450):1217
http://bmj.bmjjournals.com/cgi/content/full/328/7450/1217
HSL229
Gibson L.
Move to sell statins over the counter raises concerns.
BMJ 2004 may 22;328(7450):1221
http://bmj.bmjjournals.com/cgi/content/full/328/7450/1221-b
HSL485
Darragh D.
Mum free after murder bid
The West Australian 2004 May 22
HSL482
Mokhiber R.
Tuna Meltdown
2004 May 21
HSL483
Ranald P.
Trade text shows up freedom to lose
Newcastle Herald 2004 May 21
HSL475
Allen L.
Claims of soaring drug prices under FTA
Financial Review 2004 May 20
HSL476
Bradley M.
Drug prices will rocket, experts warn
Sydney Morning Herald 2004 May 20
HSL477
Colebatch T, Wilkinson M.
Labor warns it may block trade deal
The Age 2004 May 20
HSL478
Davidson K.
Why is Howard so loyal to US businesses?
The Age 2004 May 20
HSL479
Mitchell P.
US trade deal raises prescriptions
The Australian 2004 May 20
HSL480
Priest A.
Pondering Male Menopause
Straight.com 2004 May 20
HSL481
Bivens M.
Irrational Rationing
The Nation 2004 May 20
HSL470
McGrath C.
Study predicts trade agreement will cost PBS $1.5-bil
ABC News 2004 May 19
HSL471
Becker E.
Trade Deal Opens Australia to U.S. Manufactured Goods
2004 May 19
HSL474
Lester T.
Trade agreement may threaten PBS
ABC News 2004 May 19
HSL469
New York Sues GlaxoSmithKline Over Paxil
Associated Press 2004 May 18
HSL467
Johnson L.
Behavior drugs top kids' prescriptions: More spent than on antibiotics, asthma therapy
The New York Post 2004 May 17
HSL468
Moore P.
Gifts for Ehrlich baby raise ethical questions
The Baltimore Sun 2004 May 17
HSL466
Japsen B.
Medicine's gift culture put in an uncomfortable light
The Chicago Tribune 2004 May 16
HSL230
Burton B.
Generics industry and doctors nervous over free trade deal.
BMJ 2004 May 15;328(7449):1158
http://bmj.bmjjournals.com/cgi/content/full/328/7449/1158-a
HSL465
Lenzer L.
Whistleblower removed from job for talking to the press
The British Medical Journal 2004 May 15
HSL639
Angell M.
The New York Review of Books: The Truth About the Drug Companies
The New York Review 2004 May 15
HSL463
Armstrong D.
Pfizer Case Signals Tougher Action On Off-Label Drug Use
The Wall Street Journal 2004 May 14
HSL464
Harris G.
Pfizer to Pay $420 Million in Illegal Marketing Case
The New York Times 2004 May 14
HSL462
Mishra R.
Lapses cited in Harvard clinical trials
The Boston Globe 2004 May 13
HSL644
Weinberg P.
Fired scientists spoke out on drug approvals
Rabble News 2004 May 13
HSL5924
US Department of Justice
Warner-Lambert to pay $430 million to resolve criminal & civil health care liability relating to off-label promotion
US Department of Justice 2004 May 13
http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm
HSL8079
Kaiser Network.
Pfizer Settles Neurontin Medicaid Fraud Case for $430 Million
Kaiser Daily Reports 2004 May 13
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=23702
HSL461
Pollack A.
Suit Charges Promotion of Drug's Off-Label Use
The New York Times 2004 May 12
HSL583
Freudenheim .
Big Employers Join Forces in Effort to Negotiate Lower Drug Prices
The New York Times 2004 May 12
HSL637
Becker E.
Trade Agreement May Undercut Importing of Inexpensive Drugs
The New York Times 2004 May 12
HSL460
Silverman E.
Antidepressant prescriptions show decline: Drop follows FDA meeting on links to suicides in kids
Newark Star Ledger 2004 May 11
HSL12395
Sivagnanam G, Thirumalaikolundusubramanian P, Mohanasundaram J, Raaj AA, Namasivayam K, Rajaram S.
A survey on current attitude of practicing physicians upon usage of antimicrobial agents in southern part of India.
MedGenMed 2004 May 11;6(2):1
Link to source with long URL
HSL459
Health Canada cloaked in secrecy
The Globe and Mail 2004 May 10
HSL635
Letters to the Editor
The Wall Street Journal 2004 May 9
HSL636
Mathews A.
Invasive Procedure After Medtronic Lobbying Push, The FDA Had Change of Heart: Agency Squelches an Article Raising Doubts on Safety Of Device to Repair Artery Threat of 'Criminal Sanction'
The Wall Street Journal 2004 May 9
HSL456
Harris G.
U.S. Rules Morning-After Pill Can't Be Sold Over the Counter
The New York Times 2004 May 7
HSL457
Willman D.
Panel Wants Top Health Officials Off Drug Payrolls
The Los Angeles Times 2004 May 7
HSL458
Weiss R.
NIH Panel Backs Tighter Limits on Outside Income
The Washington Post 2004 May 7
HSL643
Cancer drug monopoly: SC issues notice
TOI Mumbai 2004 May 7
HSL633
Rabin R.
'We've been bamboozled' about cholesterol risks
Newsday.com 2004 May 6
HSL634
Vedantam S.
Drugmakers Prefer Silence On Test Data
The Washington Post 2004 May 6
HSL631
Bowe C.
Anti-depressant hearings set for this month
Financial Times 2004 May 5
HSL632
Double Dipping at NIH July 5, 2004
The Washington Post 2004 May 5
HSL2807
Helft PR, Ratain MJ, Epstein RA, Siegler M.
Inside information: Financial conflicts of interest for research subjects in early phase clinical trials.
J Natl Cancer Inst 2004 May 5;96(9):656-61
http://jncicancerspectrum.oxfordjournals.org/cgi/content/full/jnci;96/9/656
HSL455
Goozner M.
Disputing how drug costs are computed: The $800 Million Pill: The Truth Behind the Cost of New Drugs
Philadelphia Inquirer 2004 May 2
HSL231
Mayor S.
Cardiovascular disease threatens developing countries.
BMJ 2004 May 1;328(7447):1032
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1036
HSL232
Mayor S.
Squeezing academic research into a commercial straitjacket.
BMJ 2004 May 1;328(7447):1036
http://http://bmj.bmjjournals.com/cgi/content/full/328/7447/1036
HSL239
Burton B.
Drug industry to fight New Zealand's move to ban direct to consumer advertising.
BMJ 2004 May 1;328(7447):1036
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1036-d
HSL454
Bibel B.
Best Consumer Health Books 2003
Library Journal 2004 May 1
HSL1351
Watkins RS, Kimberly J Jr.
What residents don't know about physician-pharmaceutical industry interactions.
Acad Med 2004 May;79(5):432-7
http://www.academicmedicine.org/cgi/content/full/79/5/432
HSL1368
Sorensen TD, Song J, Westberg SM.
The limitation of good intentions: prescribing medications for the uninsured.
J Health Care Poor Underserved 2004 May;15(2):152-60
HSL2082
Brieger WR, Osamor PE, Salami KK, Oladepo O, Otusanya SA.
Interactions between patent medicine vendors and customers in urban and rural Nigeria.
Health Policy Plan 2004 May;19(3):177-82
http://heapol.oxfordjournals.org/cgi/reprint/19/3/177
HSL4045
Sterckx S.
Patents and access to drugs in developing countries: an ethical analysis.
Developing World Bioeth 2004 May;4(1):58-75
Link to source with long URL
HSL7938
De las Cuevas C, Sanz E.
Do therapeutic indications of antidepressants change from one year to another?
Pharmacoepidemiol Drug Saf 2004 May;13(5):309-14
Link to source with long URL
HSL10343
Divac N, Jasovic M, Djukic L, Vujnovic M, Babic D, Bajcetic M, Samardzic R.
Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia.
Pharmacoepidemiol Drug Saf 2004 May;13(5):315-22
http://www3.interscience.wiley.com/cgi-bin/abstract/107633037/ABSTRACT
HSL10347
Ho MR, Baker JE, Miller AL.
Simvastatin-induced rhabdomyolysis.
Am J Emerg Med 2004 May;22(3):234-5
http://linkinghub.elsevier.com/retrieve/pii/S0735675704000592
HSL10349
Rapaport MJ.
Follow-up of 1 mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated.
Dermatol Surg 2004 May;30(5):761-3
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1524-4725.2004.30213.x
HSL10379
Raymond EG, Spruyt A, Bley K, Colm J, Gross S, Robbins LA.
The North Carolina DIAL EC project: increasing access to emergency contraceptive pills by telephone.
Contraception 2004 May;69(5):367-72
http://linkinghub.elsevier.com/retrieve/pii/S0010782404000502
HSL10504
FDA Reanalyzes Data as Controversy Continues Over Antidepressant Use by Children and Adolescents
Psychiatr Serv 2004 May;55(5):598-599
http://www.psychservices.psychiatryonline.org/cgi/content/full/55/5/598
HSL453
Web Sparks Debate Over Drug Ads in Europe
iHealthBeat 2004 Apr 30
HSL6021
Mansfield PR.
Clarification and Update for AdWatch on Nexium dialogue
BMJ 2004 Apr 30;328
http://bmj.bmjjournals.com/cgi/eletters/328/7447/1035-a
HSL452
Kaplan J.
GOP gives green light to trade deal: Speaker Hastert has been sitting on bill for months
The Hill 2004 Apr 28
HSL451
Tierney P.
Novartis Offers Money Back on Blood Pressure Drugs
Reuters 2004 Apr 27
HSL448
Hannan E, Dunn A.
Unease over effects of medication
The Age 2004 Apr 26
HSL251
Charatan F.
Drug company raises US price of AIDS drug five-fold.
BMJ 2004 Apr 24;328(7446):974
http://bmj.bmjjournals.com/cgi/content/full/328/7446/974-a
HSL253
Tanne JH.
US consumer group names
BMJ 2004 Apr 24;328(7446):975
http://bmj.bmjjournals.com/cgi/content/full/328/7446/975-c
HSL255
Lenzer J.
New Cochrane policy tightens limits on industry funding.
BMJ 2004 Apr 24;328(7446):976
http://bmj.bmjjournals.com/cgi/content/full/328/7446/976-a
HSL1663
Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E.
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.
Lancet 2004 Apr 24;363(9418):1341-5
http://linkinghub.elsevier.com/retrieve/pii/S0140673604160431
HSL442
Depressing News on Depression
The New York Times 2004 Apr 23
HSL443
Dahir M.
Allow imported HIV/AIDS drugs: Abbott Labs' decision to raise by 500 percent the price of the AIDS drug Norvir underscores why the U.S. government must allow cheaper drugs to be imported into this country.
The Washington Blade 2004 Apr 23
HSL444
Laurance J.
Pharmaceutical companies accused of manipulating drug trials for profit
Independent.co.uk 2004 Apr 23
HSL445
Laurance J.
The link between industry, authors and their results
Independent.co.uk 2004 Apr 23
HSL446
Laurance J.
Firms become more aggressive as productivity crisis takes its toll
Independent.co.uk 2004 Apr 23
HSL447
Vedantam S.
Antidepressants Called Unsafe For Children: 4 Medications Singled Out In Analysis of Many Studies
Washington Post 2004 Apr 23
HSL441
Norman J.
Drug firm lobbyists intruded, Grassley says: 'Industry plants' attended several town meetings on a Medicare law in Iowa last week, the senator says.
Register Washington Bureau 2004 Apr 22
HSL439
Ferrie J.
When Good Drugs Go Bad: Adverse pharmaceutical reactions are a major killer, and a B.C. group is fighting to reduce the risk
The Tyee 2004 Apr 21
HSL440
Stewart H.
Aventis goes to court to block Sanofi
The Guardian 2004 Apr 21
HSL437
Study: Doctors Often Pick Costlier Drugs
The Associated Press 2004 Apr 20
HSL438
Younge G.
Gifts used to lure Aids business
The Guardian 2004 Apr 20
HSL10380
Wilson JF.
Cheaper drugs in foreign markets increase the focus on domestic drug prices.
Ann Intern Med 2004 Apr 20;140(8):677-80
http://www.annals.org/cgi/reprint/140/8/677.pdf
HSL249
Hutchinson MS.
Pharmaceutical companies and medical students: a student's view.
Med J Aust 2004 Apr 19;180(8):414
http://www.mja.com.au/public/issues/180_08_190404/hut10183_fm.html
HSL257
Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN.
The ethics of pharmaceutical industry relationships with medical students.
Med J Aust 2004 Apr 19;180(8):411-4
http://www.mja.com.au/public/issues/180_08_190404/rog10715_fm.html
HSL472
Neergaard L
Maker to pull antidepressant off market
The Associated Press 2004 Apr 19
HSL2083
Breen KJ.
The medical profession and the pharmaceutical industry: when will we open our eyes?
Med J Aust 2004 Apr 19;180(8):409-10
http://www.mja.com.au/public/issues/180_08_190404/bre10055_fm.html
HSL434
MacAfee M.
Health Canada to get clearer picture of prescription drug sales, usage
Canadian Press 2004 Apr 18
HSL435
Vedantam S.
Antidepressant Use in Children Soars Despite Efficacy Doubts
Washington Post 2004 Apr 18
HSL436
Guart A.
New York University Now A 'Meds' School: Doling out antidepressants
The New York Post 2004 Apr 18
HSL7941
't Jong GW, Stricker BH, Sturkenboom MC.
Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study.
BMJ 2004 Apr 17;328(7445):931
http://www.bmj.com/cgi/content/full/328/7445/931
HSL10382
't Jong GW, Stricker BH, Sturkenboom MC.
Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study.
BMJ 2004 Apr 17;328(7445):931
http://www.bmj.com/cgi/content/full/328/7445/931
HSL5938
Harris G.
Expert Kept From Speaking At Antidepressant Hearing
The New York Times 2004 Apr 16
Link to source with long URL
HSL433
Woodman R.
British charities call for HRT review
2004 Apr 15
HSL432
McKenzie J.
Drug Company Kickbacks: Pharmaceutical Companies Offer Doctors Free Trips, Gifts for Prescriptions
ABC News 2004 Apr 13
HSL429
Gauthier-villars D.
French Official Wants Government To Stand Neutral in Sanofi's Bid
Dow Jones Newswires 2004 Apr 12
HSL430
Pear R.
Medicare Web Site to Shine Light on Drug Prices
The New York Times 2004 Apr 12
HSL431
Lavioe D.
Drug Company Employees Face Mass Trial
Associated Press Writer 2004 Apr 12
HSL425
Young A.
Healing corrupted by practices of Big Pharma
The Toronto Star 2004 Apr 11
HSL426
Morgan S.
Opening more than the medicine cabinet
Winnipeg Free Press 2004 Apr 11
HSL427
Japsen B.
Costly dose of TV drug ads: `Why on earth' tout $10,000-$20,000-a-year specialized medications?
Chicago Tribune 2004 Apr 11
HSL258
Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL.
Efficacy and safety of antidepressants for children and adolescents.
BMJ 2004 Apr 10;328(7444):879-83
http://bmj.com/cgi/content/full/328/7444/879
HSL424
Willman D.
Curbs on Outside Deals at NIH Urged: A draft report by a blue ribbon committee calls for limits and public disclosure on consulting work, but stops short of suggesting a ban.
LA Times 2004 Apr 9
HSL422
Bush, AIDS, Big Pharma
The Nation 2004 Apr 8
HSL423
Dabade G.
High drug prices without rationale: Drug companies influence doctors and impose an unfair drug pricing regime which causes hardship to the poor
Drug Action India 2004 Apr 8
HSL421
Grady D.
Nominal Benefits Seen in Drugs for Alzheimer's Disease
The New York Times 2004 Apr 7
HSL420
Brownlee , S .
Doctors Without Borders: Why you can't trust medical journals anymore
Washington Monthly, 2004 Apr 4
HSL449
Hannan E, Dunn A.
Child depression drugs soar
The Age 2004 Apr 4
HSL245
Gulhati CM.
Marketing of medicines in India.
BMJ 2004 Apr 3;328(7443):778-9
http://bmj.bmjjournals.com/cgi/content/full/328/7443/778
HSL10374
Facing competition on veterinary medicines supply.
Vet Rec. 2004 Apr 3;154(14):417-8
HSL419
Hoen E.
Generic drugs for fighting AIDS
2004 Apr 2
HSL5832
Butzlaff M, Vollmar HC, Floer B, Koneczny N, Isfort J, Lange S.
Learning with computerized guidelines in general practice: A randomized controlled trial.
Fam Pract 2004 Apr 01;21(2):183-8
http://fampra.oxfordjournals.org/cgi/content/full/21/2/183
HSL5881
Kaufman R.
The Neurontin Controversy: The Saga of Off-Label Drug Regulation Continues
Legal Electronic Document Archive: Harvard Law School 2004 Apr 1
http://leda.law.harvard.edu/leda/data/638/Kaufman.html
HSL2486
Munce SE, Robertson EK, Sansom SN, Stewart DE.
Who is portrayed in psychotropic drug advertisements?
J Nerv Ment Dis 2004 Apr;192(4):284-8
Link to source with long URL
HSL243
Marco CA.
Pharmaceutical advertising in emergency departments.
Acad Emerg Med 2004 Apr;11(4):401-4
http://www.aemj.org/cgi/content/full/11/4/401
HSL1987
Greene JA.
Attention to 'details': etiquette and the pharmaceutical salesman in postwar American.
Soc Stud Sci 2004 Apr;34(2):271-92
HSL2080
Buchkowsky SS, Jewesson PJ.
Industry sponsorship and authorship of clinical trials over 20 years.
Ann Pharmacother 2004 Apr;38(4):579-85
http://www.theannals.com/cgi/content/full/38/4/579
HSL2801
James , M. J., L. G.
Applying a research ethics committee approach to a medical practice controversy: the case of the selective COX-2 inhibitor rofecoxib
J Med Ethics 2004 Apr;30(2):182-4
HSL2803
Lakoff , A.
The anxieties of globalization: antidepressant sales and economic crisis in Argentina
Soc Stud Sci 2004 Apr;34(2):247-69
HSL2804
Rasmussen N.
The moral economy of the drug company-medical scientist collaboration in interwar America.
Soc Stud Sci 2004 Apr;34(2):161-85
HSL2806
Landers SH, AR.
Health care lobbying in the United States
Am J Med 2004 Apr;116(7):474-7
HSL4152
Brown B, chair for Standing Committee on Health.
Opening the Medicine Cabinet: First Report on Health Aspects of Prescription Drugs.
Ottawa, Canada:: House of Commons; 2004 Apr
http://www.parl.gc.ca.
HSL10351
Fraser E, Stephen C, Bowie WR, Wetzstein M.
Availability and estimates of veterinary antimicrobial use in British Columbia.
Can Vet J 2004 Apr;45(4):309-11
Link to source with long URL
HSL10367
Nordstrom BL, Oh K, Sacks ST, L'Italien GJ.
Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study.
Antivir Ther 2004 Apr;9(2):187-95
HSL10368
James MJ, Cleland LG.
Applying a research ethics committee approach to a medical practice controversy: the case of the selective COX-2 inhibitor rofecoxib.
J Med Ethics 2004 Apr;30(2):182-4
http://jme.bmj.com/cgi/content/full/30/2/182
HSL10405
Becker D, Garcia SG, Ellertson C.
Do Mexico City pharmacy workers screen women for health risks when they sell oral contraceptive pills over-the-counter?
Contraception 2004 Apr;69(4):295-9
http://linkinghub.elsevier.com/retrieve/pii/S0010782403003275
HSL14045
Wagner JL, McCarthy E.
International differences in drug prices.
Annu Rev Public Health 2004 Apr;25:475-95
Link to source with long URL
HSL417
FDA Mum On Suicidal Side Effects?
CBS News 2004 Mar 30
HSL414
Soloman A.
A Bitter Pill
The New York Times 2004 Mar 29
HSL413
Bibbo B.
Changes in medicines prices in the UAE
The Gulf News 2004 Mar 28
HSL260
Moynihan R.
Drug spending in North America rose by 11% in 2003.
BMJ 2004 Mar 27;328(7442):727
http://bmj.bmjjournals.com/cgi/content/full/328/7442/727
HSL2379
Schroter S, Morris J, Chaudhry S, Smith R, Barratt H.
Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial.
BMJ 2004 Mar 27;328(7442):742-3
Link to source with long URL
HSL412
Basu S.
US AIDS Czar Undermines WHO Initiative
PAMBAZUKA NEWS 149 - A Weekly Electronic Newsletter For Social Justice In Africa 2004 Mar 27
HSL450
Fox M.
Prozac affects babies, sexual function - report
Reuters 2004 Mar 27
HSL411
8,000 Deaths a Day
Washington Post 2004 Mar 26
HSL410
Fox M.
Groups Accuse U.S. of Pushing Brand-Name HIV Drugs
Reuters 2004 Mar 25
HSL409
Ridgen M.
CHR vows action on toxic mix-ups: Health region hires patient safety consultant
Calgary Sun 2004 Mar 24
HSL404
Picard A.
Antidepressant users require monitoring, U.S. agency says
The Globe and Mail 2004 Mar 23
HSL405
Starnes R.
Popular antidepressants can increase suicide risk, U.S. warns: Doctors, caregivers told to be vigilant when medication starts or dose changes
Ottawa Citizen 2004 Mar 23
HSL406
Vedantam S.
New Warning Urged On Antidepressants Alert Would Address Suicidal Tendencies
The Washington Post 2004 Mar 23
HSL407
Metrick .
Is treatment worse than depression?
Rocky Mount Telegram 2004 Mar 23
HSL408
Brandt E.
Government is lax with pills
2004 Mar 23
HSL403
Liberals introduce new whistleblower legislation
CBS News Online 2004 Mar 22
HSL401
Whistleblower Protection Bill Greeted with Caution
CBC News Online 2004 Mar 21
HSL402
Bailey M.
Big Pharma's tiny gestures
The Guardian 2004 Mar 21
HSL400
Lippman A.
Osteoporosis Drug: Letter To the Editor
The New York Times 2004 Mar 20
HSL10397
Figueras A, Narvaez E, Aguilera C, Laporte JR.
Securing reproductive rights.
Lancet 2004 Mar 20;363(9413):989
http://linkinghub.elsevier.com/retrieve/pii/S0140673604157966
HSL398
Richwine L.
Judge Rules Against Bayer on Poultry Antibiotic
Reuters 2004 Mar 17
HSL399
Carroll R.
Experts express doubts on anti-Aids birth drug
The Guardian 2004 Mar 17
HSL262
What's wrong with CME.
CMAJ 2004 Mar 16;170(6):917, 919
http://www.cmaj.ca/cgi/content/full/170/6/917
HSL263
Meek C.
Spanish journal wins lawsuit over COX-2 drug editorial.
CMAJ 2004 Mar 16;170(6):940
http://http://www.cmaj.ca/cgi/content/full/170/6/940-a
HSL381
Novelli , W. D
Letter to Pharmaceutical CEOs
2004 Mar 16
HSL395
Keep Antibiotics Working Praises Ruling Upholding Proposed Ban of Cipro-Like Drugs for Poultry; Urges Bayer to Comply with Ban
U.S. Newswire 2004 Mar 16
HSL396
Connolly .
2003 Drug Spending Up Despite Pressure to Cut Costs
The Washington Post 2004 Mar 16
HSL397
Mathews .
FDA Explores Obstacles to New Drugs Agency Calls for New Research And Tools -- and Thinks It Can Help
The Wall Street Journal 2004 Mar 16
HSL5926
What's wrong with CME? (editorial).
CMAJ 2004 Mar 16;170(6):917
http://www.cmaj.ca/cgi/reprint/170/6/917
HSL394
Zimmerman R.
New Ways to Take Old Drugs: Help Patients, Extend Patents
The Wall Street Journal 2004 Mar 15
HSL7948
Harmon GN, Lefante J, Roy W, Ashby KH, Jackson D, Barnard D, Smart A, Webber L.
Outpatient medication assistance program in a rural setting.
Am J Health Syst Pharm 2004 Mar 15;61(6):603-7
http://www.ajhp.org/cgi/reprint/61/6/603
HSL5847
Sweet M.
Development of strategies to encourage adoption of best evidence into practice in Australia: workshop overview.
Med J Aust 2004 Mar 15;180(6)
http://www.mja.com.au/public/issues/180_06_150304/swe10882_fm.html
HSL5871
Evans D.
Placebo: Mind Over Matter in Modern Medicine
New York, NY: HarperCollins; 2004
HSL10407
Florin TH, Kerr SJ, Mant A, Horn FE, McGeechan K, Sayer GP, Dowden JS.
Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners.
Med J Aust 2004 Mar 15;180(6):310-2
http://www.mja.com.au/public/issues/180_06_150304/letters_150304_fm-4.html
HSL392
Langley A.
African Aids drug plan faces collapse
The Observer 2004 Mar 14
HSL393
Safer M.
Prescriptions And Profit
CBS News 2004 Mar 14
HSL389
Boseley S.
The Riddle of the Drug Regulators: Critics press for review of licensing system
The Guardian 2004 Mar 13
HSL390
Willman D.
Ex-NIH Director Now Favors Limiting Drug-Company Ties: Harold Varmus lifted conflict-of-interest rules at National Institutes of Health. Many agency officials have consulting deals with the industry.
The Los Angeles Times 2004 Mar 13
HSL391
Charity chief slams drug watchdog
BBC News 2004 Mar 13
HSL267
Slutsky AS, Lavery JV.
Data safety and monitoring boards.
N Engl J Med 2004 Mar 11;350(11):1143-7
http://content.nejm.org/cgi/content/full/350/11/1143
HSL386
Horton , R .
Review: The Dawn of McScience
New York Books 2004 Mar 11
HSL387
Garnaut , J .
Drug costs will rise with deal
Sydney Morning Herald 2004 Mar 11
HSL388
Pugh T
Medicare plan cost estimates ordered withheld
Knight Ridder Newspapers 2004 Mar 11
Nil
HSL385
Rapaport , L .
Doctors take on drug makers: Physicians oppose the tracking of their prescriptions for marketing purposes
The Sacramento Bee 2004 Mar 10
HSL382
Pear , R .
Medicare Nominee Backs Drug Imports
The New York Times 2004 Mar 9
HSL383
Roberts , W .
Kerry Tells Illinois Voters Drug Costs in U.S. Are 'a Crisis'
Bloomberg News 2004 Mar 9
HSL384
Winslow R.
For Bristol-Myers, Challenging Pfizer Was a Big Mistake: In a Rare Head-to-Head Study, Lipitor Beats Pravachol at Reducing Heart Risk: A New Push on Cholesterol
The Wall Street Journal 2004 Mar 9
HSL380
Kolata , G .
My Drug Study Sounds Catchier Than Yours
The New York Times 2004 Mar 7
HSL10408
Edmondson PW.
Illegal importation and use of farm animal medicines.
Vet Rec 2004 Mar 6;154(10):311
HSL378
Rovner J .
Thompson Might Back Drug Reimportation - If Restricted
CongressDaily 2004 Mar 5
HSL379
Kolata , G .
Companies Facing Ethical Issue as Drugs Are Tested Overseas
The New York Times 2004 Mar 5
HSL4136
IMS Health.
Total US promotional spending by type, 2003.
: IMS Health.; 2004 Mar 5
Link to source with long URL
HSL374
Hallam , K .
Senators Grassley, Kennedy Are Crafting Drug Import Measure
Bloomberg News 2004 Mar 4
HSL375
Richwine , L .
Consumer Group Says Ban Cholesterol Drug
Reuters 2004 Mar 4
HSL376
Caldwell , A .
US free trade deal concerns roll in
ABC Online 2004 Mar 4
HSL377
Anti-Cholesterol Drug Ban Sought
CBS News 2004 Mar 4
HSL1336
Zehnder S, Bruppacher R, Ruppanner H, Hersberger K.
Swiss community pharmacies' on the Web and pharmacists' experiences with E-commerce: longitudinal study and Internet-based questionnaire survey
J Med Internet Res 2004 Mar 3;6(1):e9
HSL266
Zoutman DE, Ford BD, Bassili AR.
The confidentiality of patient and physician information in pharmacy prescription records.
CMAJ 2004 Mar 2;170(5):815-6
http://www.cmaj.ca/cgi/content/full/170/5/815
HSL372
Kondro , W AND, B .
Drug company experts advised staff to withhold data about SSRI use in children: A 1993-1996 Industry Study Showed That Paroxetine Was No More Effective Than Placebo In Treating Pediatric Depression.
Canadian Medical Association Journal 2004 Mar 2
HSL373
Willman , D .
Ethics Policy Announced for NIH Officials
The Los Angeles Times 2004 Mar 2
HSL5845
Sanson-Fisher RW, Grimshaw JM, Eccles MP.
The science of changing providers' behaviour: the missing link in evidence-based practice.
Med J Aust 2004 Mar 1;180(5):205-6
http://www.mja.com.au/public/issues/180_05_010304/san10013_fm.html
HSL5860
Berger RG, Kichak JP.
Computerized physician order entry: helpful or harmful?
J Am Med Inform Assoc 2004 Mar-Apr 01;11(2):100-3
http://www.jamia.org/cgi/content/full/11/2/100
HSL1372
Using drug samples can hinder quality
Healthcare Benchmarks Qual Improv 2004 Mar;11(3):34-5
HSL1660
Timimi S, Moncrieff J, Jureidini J, Leo J, Cohen D, Whitfield C, Double D, Bindman J, Andrews H, Asen E, Bracken P, Duncan B, Dunlap M, Albert G, Green M, Greening T, Hill J, Huws R, Karon B, Kean B, McCubbin M, Miatra B, Mosher L, Parry S, DuBose Ravenel
A critique of the international consensus statement on ADHD.
Clin Child Fam Psychol Rev 2004 Mar;7(1):59-63
HSL10336
Choonara I.
Unlicensed and off-label drug use in children: implications for safety.
Expert Opin Drug Saf 2004 Mar;3(2):81-3
HSL10338
Barry M, Tilson L, Ryan M.
Patient co-payment for prescription medicines across Europe--how do we compare?
Ir Med J 2004 Mar;97(3):69-70
HSL10406
Griffiths S.
Betting on biogenerics.
Nat Rev Drug Discov 2004 Mar;3(3):197-8
HSL10416
Johnson KC, Klesges LM, Somes GW, Coday MC, DeBon M.
Access of over-the-counter nicotine replacement therapy products to minors.
Arch Pediatr Adolesc Med 2004 Mar;158(3):212-6
http://archpedi.ama-assn.org/cgi/content/full/158/3/212
HSL281
Tuffs A.
Only 6% of drug advertising material is supported by evidence.
BMJ 2004 Feb 28;328(7438):485
http://bmj.bmjjournals.com/cgi/content/full/328/7438/485-a
HSL283
McPherson K, Hemminki E.
Synthesising licensing data to assess drug safety.
BMJ 2004 Feb 28;328(7438):518-20
http://bmj.bmjjournals.com/cgi/content/full/328/7438/518
HSL340
Munro , M .
Research turns deadly: Four-year-old Ryan died at an Ottawa hospital from an experimental drug given at 25 times the proper dose
CanWest News Service 2004 Feb 28
HSL344
Harris , G .
Pfizer Gives Up Testing Viagra on Women
The New York Times 2004 Feb 28
HSL10410
Greet T.
Veterinary medicines.
Vet Rec 2004 Feb 28;154(9):276
HSL335
Landers P.
Drug Industry's Big Push Into Technology Falls Short : Testing Machines Were Built To Streamline Research -- But May Be Stifling It
The Wall Street Journal 2004 Feb 26
HSL337
Mandal , V .
Women ponder class-action suit
The Leader-Post 2004 Feb 26
HSL341
Official Defends Polio Vaccinne Boycott
The New York Times 2004 Feb 26
HSL342
FDA Weighs Putting Limits on Acne Drug
The Associated Press 2004 Feb 26
HSL333
Munro , M .
UBC broke federal ethics rules by failing to adequately warn patients: University fixed drug-trial breach after discovering shortcomings
The Vancouver Sun 2004 Feb 25
HSL334
Munro , M .
UBC broke drug-trial rules for years, documents show
CanWest News Service 2004 Feb 25
HSL327
Cornacchia , C .
Cozying up to drug firms disturbs some physicians: Heart doctor complained to professional order after being invited to refer patients to clinical trial
The Gazette 2004 Feb 24
HSL330
Monbiot , G .
The corporate stooges who nobble serious science: The MMR scandal shows a business riddled with conflicts of interest
The Guardian 2004 Feb 24
HSL332
Zuger A .
Essay: When Your Doctor Goes to the Beach, You May Get Burned
NYTimes 2004 Feb 24
HSL285
Robinson AR, Hohmann KB, Rifkin JI, Topp D, Gilroy CM, Pickard JA, Anderson RJ.
Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship.
Arch Intern Med 2004 Feb 23;164(4):427-32
http://archinte.ama-assn.org/cgi/content/full/164/4/427
HSL326
Munro , M .
Doctors pressure human guinea pigs: MDs are paid up to $5,000 per patient to sign up volunteers for drug trials
Vancouver Sun 2004 Feb 23
HSL2799
Food and Drug Administration, HHS.
Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date.
Federal Register: February 23, 2004 (Volume 69, Number 35). 2004 Feb 23;69(35)
http://fr.cos.com/cgi-bin/getRec?id=20040223a107
HSL289
Burton B.
Australia makes concessions on drug approvals after US pressure.
BMJ 2004 Feb 21;328(7437):425
http://bmj.bmjjournals.com/cgi/content/full/328/7437/425-b
HSL290
Little P, Dorward M, Warner G, Stephens K, Senior J, Moore M.
Importance of patient pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study.
BMJ 2004 Feb 21;328(7437):444
http://bmj.bmjjournals.com/cgi/content/full/328/7437/444
HSL291
Britten N.
Patients' expectations of consultations.
BMJ 2004 Feb 21;328(7437):416-7
http://bmj.bmjjournals.com/cgi/content/full/328/7437/416
HSL325
Taylor , H .
The Drug Price Battle Continues : Politicians will try to cool public opinion as voters steam over drug prices.
Pharmaceutical Executive 2004 Feb 20
HSL324
De Vries, R .
Buying ethics
The Guardian Weekly 2004 Feb 19
HSL323
Vaughan , M .
Grassley Says Australia Drug Provision Intrudes On Hill Debate
CongressDaily 2004 Feb 18
HSL223
Moore , P .
From coloured tabs to computerized signals: How Canada tracks dangerous drugs
CBC News 2004 Feb 17
http://www.cbc.ca/news/adr/
HSL224
Faint Warning Generation Rx
CBS news 2004 Feb 17
http://www.cbc.ca/disclosure/archives/040217_adr/resources.html
HSL276
Garland EJ.
Facing the evidence: antidepressant treatment in children and adolescents.
CMAJ 2004 Feb 17;170(4):489-91
http://www.cmaj.ca/cgi/content/full/170/4/489
HSL287
Hirsch L.
Randomized clinical trials: what gets published, and when?
CMAJ 2004 Feb 17;170(4):481-3
http://www.cmaj.ca/cgi/content/full/170/4/481
HSL319
Branswell H .
Suppressed data from negative drug trials distorts science: Journal
Canadian Press 2004 Feb 17
HSL321
Mickleburgh , R .
Antidepressants found ineffective on teenagers
Globe and Mail 2004 Feb 17
HSL2086
Bhandari M, Busse JW, Jackowski D, Montori VM, Schunemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ.
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
CMAJ 2004 Feb 17;170(4):477-80
http://www.cmaj.ca/cgi/content/full/170/4/477
HSL10870
Sharp increase in children hurt by prescription drugs
CBC News 2004 Feb 17
http://www.cbc.ca/news/story/2004/02/17/drug_reaction040217.html
HSL220
Holladay , R .
Student's suicide cries out to FDA for drug warnings
Indianapolis Star 2004 Feb 15
HSL221
Dickey , F .
Physician and Author Jay Cohen Says Pharmaceutical Companies Are Endangering Lives by Recommending Drug Doses That Are Too High for Many Patients
The LA Times 2004 Feb 15
HSL293
Moynihan R.
Controversial disease dropped from Prozac product information.
BMJ 2004 Feb 14;328(7436):365
http://bmj.bmjjournals.com/cgi/content/full/328/7436/365
HSL294
Ford N, Wilson D, Bunjumnong O, von Schoen Angerer T.
The role of civil society in protecting public health over commercial interests: lessons from Thailand.
Lancet 2004 Feb 14;363(9408):560-3
Link to source with long URL
HSL10420
Walley T, Folino-Gallo P, Schwabe U, van Ganse E; EuroMedStat group.
Variations and increase in use of statins across Europe: data from administrative databases.
BMJ 2004 Feb 14;328(7436):385-6
http://www.bmj.com/cgi/content/full/328/7436/385
HSL219
Naedele , W.f
19 quit Lilly drug trial after a death
Philadelphia Inquirer 2004 Feb 13
HSL218
Wall J.K
Death fuels fallout in drug trial: 20% of patients exit Lilly's study for duloxetine after girl's suicide
Indianapolis Star 2004 Feb 12
HSL216
One in Four Americans Discuss Costs of Medicines With Doctor
Wall Street Journal 2004 Feb 11
HSL215
Women In Government Announces Partnership With Bristol-Myers Squibb Foundation to Convene First Ever Summit of State Offices of Women's Health
Yahoo News 2004 Feb 10
HSL5609
Kramer TA.
A plea for biased information.
MedGenMed 2004 Feb 10;6(1):31
Link to source with long URL
HSL213
Lemonick , M. D
Prescription For Suicide? British authorities say some antidepressants can be deadly for kids. Now the FDA is investigating
Time Magazine 2004 Feb 9
HSL214
Wall JK
Woman participating in Lilly trial hangs self: Coroner will examine whether experimental drug played possible part in19-year-old's suicide.
The Indy Star 2004 Feb 9
HSL296
Goulding MR.
Inappropriate medication prescribing for elderly ambulatory care patients.
Arch Intern Med 2004 Feb 9;164(3):305-12
http://archinte.ama-assn.org/cgi/content/full/164/3/305
HSL211
Sellar D.
Cancer group has Big Pharma roots
Toronto Star 2004 Feb 7
HSL212
Willcocks P.
Health care consumers need a voice
Vancouver Sun 2004 Feb 7
HSL297
Gibson L.
Spanish drug editor wins case brought by Merck, Sharp Dohme.
BMJ 2004 Feb 7;328(7435):307
http://bmj.bmjjournals.com/cgi/content/full/328/7435/307-b
HSL298
Moynihan R.
FDA advisory panel calls for suicide warnings over new antidepressants.
BMJ 2004 Feb 7;328(7435):303
http://bmj.bmjjournals.com/cgi/content/full/328/7435/303-a
HSL299
Moynihan R.
Drug company targets US state health officials.
BMJ 2004 Feb 7;328(7435):306
http://bmj.bmjjournals.com/cgi/content/full/328/7435/306
HSL4957
Ong A, Mansfield PR.
Controversies: Should free drug samples be banned?
Australian Doctor Weekly 2004 Feb 6
HSL300
Mello MM, Studdert DM, Brennan TA.
The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
N Engl J Med 2004 Feb 5;350(6):608-13
http://content.nejm.org/cgi/content/full/350/6/608
HSL207
Antidepressants May Cause Suicides
The New York Times 2004 Feb 4
HSL208
Landrigan K .
State may limit gifts from drug companies
Nashua Telegraph 2004 Feb 4
HSL209
Wahlberg D.
Advertisers probe brains, raise fears
The Atlanta Journal-Constitution 2004 Feb 4
HSL203
Vedantam , S .
FDA Links Antidepressants, Youth Suicide Risk
Washington Post 2004 Feb 3
HSL204
Roner L .
A matter of trust
Eye For Pharma 2004 Feb 3
HSL205
Boseley , S .
Company 'held back' data on drug for children: Antidepressant had no effect, leak reveals
The Guardian 2004 Feb 3
HSL206
Lawmaker Seeks Data on Antidepressants for Kids
Reuters 2004 Feb 3
HSL301
Mor